902763-53-5

Basic information

• Product Name: 5-[4-(4-fluorophenoxy)-benzenesulfonyl]-octahydro-furo[3,2-c]pyridine-4-carboxylic acid
• CAS NO: 902763-53-5
• Molecular Weight: 417.415
• Mol File: 902763-53-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 5-[4-(4-fluorophenoxy)-benzenesulfonyl]-octahydro-furo[3,2-c]pyridine-4-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-[4-(4-fluorophenoxy)-benzenesulfonyl]-octahydro-furo[3,2-c]pyridine-4-carboxylic acid(902763-53-5)
• EPA Substance Registry System: 5-[4-(4-fluorophenoxy)-benzenesulfonyl]-octahydro-furo[3,2-c]pyridine-4-carboxylic acid(902763-53-5)

Safety Data

• Hazardous Substances Data: 902763-53-5(Hazardous Substances Data)

Upstream product

• 902763-63-7 4,5,6,7-tetrahydro-furo[3,2-c]pyridine-4-carboxylic acid 
• 192329-91-2 4-(4-fluorophenoxy)benzenesulfonyl chloride 

Downstream Products

• 902763-54-6 5-[4-(4-fluorophenoxy)-benzenesulfonyl]-octahydro-furo[3,2-c]pyridin-4-(N-hydroxy)-carboxamide 

Relevant articles and documents

TETRAHYDROFURANE DERIVATIVES FOR USE AS INHIBITORS OF MATRIX METALLOPROTEINASES

The compounds of formula (I) are suitable for producing drugs for use in the prophylaxis and therapy of diseases which are associated with an increased matrix metalloproteinase activity. Examples of such diseases are degenerative articular diseases such as osteoarthroses, spondyloses, chondroporosis after articular trauma or prolonged joint immobilization after meniscus or patella injuries or rupture of a ligament, or a disease of the connective tissue such as collagenoses, periodontal diseases, defective wound healing, or chronic diseases of the locomotor system such as inflammatory, immunologically or metabolically mediated acute or chronic arthritides, arthropathies, myalgias or disorders of the bone metabolism or an ulceration, atherosclerosis or stenosis or an inflammatory disease or a tumor disease, tumor metastatic spread, cachexia, anorexia or septic shock.